Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Sensei Biotherapeutics, Inc., an immuno-oncology company, engages in the discovery and development of therapeutics for cancer patients. The company's Tumor Microenvironment Activated Biologics platform is designed to generate highly selective therapeutics that disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. It also offers SNS-101, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors. The company's pipeline includes SNS-103 and SNS-102, an active monoclonal antibody, which are in early development stages for the treatment of solid tumors, as well as SNS-201 is a bispecific antibody targeting CD28. It has a collaboration with The University of Washington to conduct preclinical studies for its SNS-101 program. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland. more
Time Frame | SNSE | Sector | S&P500 |
---|---|---|---|
1-Week Return | 4.63% | -0.94% | -2.6% |
1-Month Return | -24.67% | -5.08% | -1.08% |
3-Month Return | -9.62% | -10.62% | 3.45% |
6-Month Return | -28.75% | -6.18% | 8.57% |
1-Year Return | -32.54% | 1.98% | 24.3% |
3-Year Return | -92.21% | -0.93% | 25.58% |
5-Year Return | -97.61% | 33.84% | 84.07% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Cost of Revenue | 73.00K | 209.00K | 685.00K | 1.81M | 571.00K | [{"date":"2019-12-31","value":4.04,"profit":true},{"date":"2020-12-31","value":11.56,"profit":true},{"date":"2021-12-31","value":37.89,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":31.58,"profit":true}] |
Gross Profit | (73.00K) | (209.00K) | (685.00K) | (1.81M) | (571.00K) | [{"date":"2019-12-31","value":-7300000,"profit":false},{"date":"2020-12-31","value":-20900000,"profit":false},{"date":"2021-12-31","value":-68500000,"profit":false},{"date":"2022-12-31","value":-180800000,"profit":false},{"date":"2023-12-31","value":-57100000,"profit":false}] |
Gross Margin | (Infinity%) | (Infinity%) | (Infinity%) | (Infinity%) | (Infinity%) | [{"date":"2019-12-31","value":null,"profit":false},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}] |
Operating Expenses | 12.44M | 18.71M | 37.48M | 50.19M | 37.06M | [{"date":"2019-12-31","value":24.78,"profit":true},{"date":"2020-12-31","value":37.29,"profit":true},{"date":"2021-12-31","value":74.68,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":73.85,"profit":true}] |
Operating Income | (12.44M) | (19.45M) | (37.48M) | (50.19M) | (37.06M) | [{"date":"2019-12-31","value":-1243500000,"profit":false},{"date":"2020-12-31","value":-1945100000,"profit":false},{"date":"2021-12-31","value":-3748200000,"profit":false},{"date":"2022-12-31","value":-5018800000,"profit":false},{"date":"2023-12-31","value":-3706400000,"profit":false}] |
Total Non-Operating Income/Expense | (6.56M) | (2.34M) | 818.00K | 3.16M | 6.46M | [{"date":"2019-12-31","value":-101.52,"profit":false},{"date":"2020-12-31","value":-36.18,"profit":false},{"date":"2021-12-31","value":12.66,"profit":true},{"date":"2022-12-31","value":48.96,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Pre-Tax Income | (16.74M) | (20.10M) | (36.79M) | (48.59M) | (34.10M) | [{"date":"2019-12-31","value":-1674000000,"profit":false},{"date":"2020-12-31","value":-2010000000,"profit":false},{"date":"2021-12-31","value":-3679400000,"profit":false},{"date":"2022-12-31","value":-4858800000,"profit":false},{"date":"2023-12-31","value":-3410100000,"profit":false}] |
Income Taxes | 2.25M | 529.00K | 670.00K | 219.00K | 100.00K | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":23.46,"profit":true},{"date":"2021-12-31","value":29.71,"profit":true},{"date":"2022-12-31","value":9.71,"profit":true},{"date":"2023-12-31","value":4.43,"profit":true}] |
Income After Taxes | (19.00M) | (20.63M) | (37.46M) | (48.81M) | (34.20M) | [{"date":"2019-12-31","value":-1899500000,"profit":false},{"date":"2020-12-31","value":-2062900000,"profit":false},{"date":"2021-12-31","value":-3746400000,"profit":false},{"date":"2022-12-31","value":-4880700000,"profit":false},{"date":"2023-12-31","value":-3420100000,"profit":false}] |
Income From Continuous Operations | (16.74M) | (20.10M) | (36.79M) | (48.59M) | (38.92M) | [{"date":"2019-12-31","value":-1674000000,"profit":false},{"date":"2020-12-31","value":-2010000000,"profit":false},{"date":"2021-12-31","value":-3679400000,"profit":false},{"date":"2022-12-31","value":-4858800000,"profit":false},{"date":"2023-12-31","value":-3891900000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (19.00M) | (20.63M) | (37.46M) | (48.81M) | (34.10M) | [{"date":"2019-12-31","value":-1899500000,"profit":false},{"date":"2020-12-31","value":-2062900000,"profit":false},{"date":"2021-12-31","value":-3746400000,"profit":false},{"date":"2022-12-31","value":-4880700000,"profit":false},{"date":"2023-12-31","value":-3410100000,"profit":false}] |
EPS (Diluted) | - | (23.52) | (1.36) | (1.58) | (1.22) | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-2352.22,"profit":false},{"date":"2021-12-31","value":-136,"profit":false},{"date":"2022-12-31","value":-158,"profit":false},{"date":"2023-12-31","value":-122,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
SNSE | |
---|---|
Cash Ratio | 8.64 |
Current Ratio | 8.84 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
SNSE | |
---|---|
ROA (LTM) | -27.03% |
ROE (LTM) | -45.17% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
SNSE | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.14 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.86 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
SNSE | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 0.00 |
P/B | 0.25 |
Price/FCF | NM |
EV/R | 0.00 |
EV/Ebitda | 1.36 |
Sensei Biotherapeutics Inc (SNSE) share price today is $0.452
Yes, Indians can buy shares of Sensei Biotherapeutics Inc (SNSE) on Vested. To buy Sensei Biotherapeutics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SNSE stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Sensei Biotherapeutics Inc (SNSE) via the Vested app. You can start investing in Sensei Biotherapeutics Inc (SNSE) with a minimum investment of $1.
You can invest in shares of Sensei Biotherapeutics Inc (SNSE) via Vested in three simple steps:
The 52-week high price of Sensei Biotherapeutics Inc (SNSE) is $1.94. The 52-week low price of Sensei Biotherapeutics Inc (SNSE) is $0.38.
The price-to-earnings (P/E) ratio of Sensei Biotherapeutics Inc (SNSE) is
The price-to-book (P/B) ratio of Sensei Biotherapeutics Inc (SNSE) is 0.25
The dividend yield of Sensei Biotherapeutics Inc (SNSE) is 0.00%
The market capitalization of Sensei Biotherapeutics Inc (SNSE) is $11.32M
The stock symbol (or ticker) of Sensei Biotherapeutics Inc is SNSE